Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Share News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Tue, 02nd Jun 2015 14:55

UK Earnings, Trading Statements Calendar 
Wednesday, June 3 
Dixons CarphoneQ4 Trading Statement
Mears GroupInterim Management Statement 
International Consolidated Airlines GroupMay Traffic Statistics
CaffynsFull Year Results
Advanced OncotherapyFull Year Results 
Workspace GroupFull Year Results
Alternative NetworksHalf Year Results
EasyhotelHalf Year Results
Shires IncomeFull Year Results
MS InternationalFull Year Results
FindelFull Year Results
The Investment CoInterim Management Statement 
RMTrading Statement 
Servelec GroupInterim Management Statement 
HgCapital TrustInterim Management Statement 
Impax Environmental MarketsInterim Management Statement 
Herald Investment TrustInterim Management Statement 
iEnergizerTrading Statement 
FutureTrading Statement 
First DerivativesTrading Statement 
QuindellFull Year Results
Ruffer InvestmentInterim Management Statement 
Greencoat UK WindInterim Management Statement 
WH SmithTrading Statement 
Thursday, June 4 
EasyJetMay Traffic Statistics
Johnson MattheyFull Year Results
Pets At HomeFull Year Results
VPFull Year Results
WincantonFull Year Results
888 HoldingsQ1 Interim Management Statement
WANdiscoQ1 Update
Asian Total Return Investment CoInterim Management Statement 
Promethean WorldInterim Management Statement 
JKX Oil & GasInterim Management Statement 
Genesis Emerging Markets FundInterim Management Statement 
Graphene NanochemFull Year Results
Montanaro European Smaller Companies TrustFull Year Results
New India Investment TrustFull Year Results
Northern Investors CoFull Year Results
Air PartnerFull Year Results
Friday, June 5 
Halfords GroupFull Year Results
BellwayInterim Management Statement 
Fuller Smith & TurnerFull Year Results
KCOM GroupFull Year Results
Edinburgh Worldwide Investment TrustHalf Year Results
Monday, June 8 
Drax GroupInterim Management Statement 
Falkland Islands HoldingsFull Year Results
Phoenix IT GroupFull Year Results
IDOXHalf Year Results
AbzenaFull Year Results 
Tuesday, June 9 
RPC GroupFull Year Results
CarcloFull Year Results
Energy Assets GroupFull Year Results
Oxford InstrumentsFull Year Results
Picton Property IcomeFull Year Results
Park GroupFull Year Results
Gooch & HousegoHalf Year Results
Custodian REITFull Year Results
OMGFull Year Results
CML MicrosystemsFull Year Results
Iomart GroupFull Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2018 11:15

Abzena Shares Suspended As Acquisition Becomes Effective (ALLISS)

LONDON (Alliance News) - Abzena PLC shares were suspended from trading on AIM on Thursday as the company's acquisition by Astro BidCo Ltd became effective.The biopharmaceutical firm its

Read more
2 Oct 2018 14:20

Abzena Acquisition By Astro Bidco Gains Shareholder Approval

LONDON (Alliance News) - Biopharmaceutical technology firm Abzena PLC said on Tuesday that at a court meeting and general meeting held earlier, its acquisition by Astro Bidco Ltd was approved by a

Read more
10 Sep 2018 15:46

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 11 SeptemberAshtead GroupBilbyCohortMulberry 12 Direct Oil & UK 13 14 UK

Read more
16 Aug 2018 10:37

WINNERS & LOSERS SUMMARY: Acquisition Puts On The Beach On Buying Wave

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - down 2.6%, Legal & down down 0.7%,

Read more
16 Aug 2018 10:18

Abzena agrees to be taken over by US private equity firm WCAS

(Sharecast News) - Abzena has agreed to be taken over by US private equity firm WCAS in a £34.4m deal.

Read more
16 Aug 2018 10:09

Abzena To Go Private As It Agrees GBP34 Million Takeover By Astro

LONDON (Alliance News) - Shares in biopharmaceutical technology firm Abzena PLC rocketed Thursday after agreed to a takeover valuing the firm at around GBP34.4 million.Astro Bidco Ltd, a up

Read more
14 Jun 2018 11:56

Shares In Abzena Fall As It Seeks To Monetise Royalty-Bearing Products

LONDON (Alliance News) - Abzena PLC on Thursday said it has entered into a non-binding heads of terms agreement with an unconnected third party as it requires additional funding to support its in

Read more
14 Jun 2018 11:00

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut

Read more
20 Jan 2017 10:42

WINNERS & LOSERS SUMMARY: Shares Of Upbeat Synthomer Hit Record High

Read more
20 Jan 2017 10:29

Abzena signs licensing agreement for 'ThioBridge' technology

(ShareCast News) - Life sciences group Abzena announced on Friday that it has signed a licensing agreement with an unnamed San Diego-based biopharmaceutical company for its site-specific 'ThioBridge' antibody drug conjugate linker technology. The AIM-traded company said 'ThioBridge' links antibodies

Read more
20 Jan 2017 08:33

Abzena Shares Jump On ThioBridge Licensing Agreement In US

Read more
22 Dec 2016 14:20

Abzena inks licence agreement with Trieza Therapeutics

(ShareCast News) - Life-sciences group Abzena has inked a licence agreement with start-up biotechnology company Trieza Therapeutics. US-based Trieza specialises in the discovery and development of immunomodulatory oncolytic viruses. Abzena has granted Trieza an exclusive licence to an undisclosed a

Read more
2 Nov 2016 14:11

Abzena shares plunge as Gilead drops simtuzumab

(ShareCast News) - Life sciences group Abzena noted on Wednesday that during Gilead Sciences' announcement of third quarter earnings on 1 November, it stated that no further development of simtuzumab will be pursued. The AIM-traded firm also noted that GS-5745 will not be progressed further by Gilea

Read more
21 Oct 2016 13:47

Abzena notes progress with Composite Human Antibody tech

(ShareCast News) - Life sciences group Abzena noted on Friday that Gilead Sciences has announced top line Phase II clinical study results of its product, GS-4997 (selonsertib) in combination with the investigational monoclonal antibody, simtuzumab (SIM) or SIM alone, in patients with non-alcoholic s

Read more
6 Sep 2016 15:07

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.